Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · IEX Real-Time Price · USD
1.460
+0.080 (5.80%)
At close: Jul 23, 2024, 4:00 PM
1.440
-0.020 (-1.37%)
After-hours: Jul 23, 2024, 7:06 PM EDT

Akebia Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2012
Revenue
187.23194.62292.48211.65294.64335
Upgrade
Revenue Growth (YoY)
-30.88%-33.46%38.19%-28.17%-12.05%61.26%
Upgrade
Cost of Revenue
65.5674.1585.57150.67296.48145.34
Upgrade
Gross Profit
121.66120.47206.9260.98-1.83189.67
Upgrade
Selling, General & Admin
100.62100.23138.6174.14154.1149.46
Upgrade
Research & Development
53.1263.08129.99147.85218.49322.97
Upgrade
Other Operating Expenses
-0.440.1815.933.493.413.53
Upgrade
Operating Expenses
153.31163.49284.52325.48375.99475.95
Upgrade
Operating Income
-31.65-43.02-77.6-264.5-377.83-286.29
Upgrade
Interest Expense / Income
6.976.0315.6919.948.87-0.79
Upgrade
Other Expense / Income
4.422.870.94-2.41-1.860.79
Upgrade
Pretax Income
-43.03-51.93-94.23-282.02-384.84-286.29
Upgrade
Income Tax
00000-6.63
Upgrade
Net Income
-43.03-51.93-94.23-282.02-384.84-279.66
Upgrade
Shares Outstanding (Basic)
205187183166138118
Upgrade
Shares Outstanding (Diluted)
205187183166138118
Upgrade
Shares Change
10.93%2.56%10.14%19.85%16.95%104.00%
Upgrade
EPS (Basic)
-0.23-0.28-0.52-1.70-2.78-2.36
Upgrade
EPS (Diluted)
-0.23-0.28-0.52-1.70-2.78-2.36
Upgrade
Free Cash Flow
-25.28-23.38-73.27-253.02-110.71-264.1
Upgrade
Free Cash Flow Per Share
-0.12-0.13-0.40-1.52-0.80-2.23
Upgrade
Gross Margin
64.98%61.90%70.74%28.81%-0.62%56.62%
Upgrade
Operating Margin
-16.90%-22.10%-26.53%-124.97%-128.23%-85.46%
Upgrade
Profit Margin
-22.98%-26.68%-32.22%-133.25%-130.61%-83.48%
Upgrade
Free Cash Flow Margin
-13.50%-12.02%-25.05%-119.55%-37.57%-78.83%
Upgrade
EBITDA
7.34-4.05-43.26-225.96-343.32-250.67
Upgrade
EBITDA Margin
3.92%-2.08%-14.79%-106.76%-116.52%-74.83%
Upgrade
Depreciation & Amortization
43.4141.8535.2836.1332.6636.42
Upgrade
EBIT
-36.06-45.89-78.54-262.09-375.97-287.08
Upgrade
EBIT Margin
-19.26%-23.58%-26.85%-123.83%-127.60%-85.70%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).